CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation

Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. CXCL13 (chemokine [C-X-C motif] ligand 1) is a chemoattractant produced within secondary lymphoid organs necess...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emma S. Crichton, MD, MPH, Shan Zeng, MD, PhD, G. Michael La Muraglia, II, PhD, I. Raul Badell, MD
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/944df3f4cb9c4559bf0b7959bcd41b16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!